After Cervical Artery Dissection, Early Anticoagulant Might Be Better
PHOENIX — Anticoagulation worked at least as well as antiplatelet medication for stroke prevention after cervical artery dissection, an observational study suggested. Subsequent ischemic stroke was numerically but not significantly less common with anticoagulation than with antiplatelet use in this population both at 30 days (adjusted HR 0.71, 95% CI 0.45-1.12) and 180 days (adjusted […]
Anticoagulation Again Flops for Outpatient COVID-19
CHICAGO — For outpatient COVID-19, prophylactic anticoagulation with rivaroxaban (Xarelto) did not improve outcomes in elevated thrombotic risk patients, the PREVENT trial showed. Compared with placebo, giving the direct-acting oral anticoagulant (DOAC) for 35 days in non-hospitalized patients with symptomatic COVID-19 who had at least one risk factor for thrombosis didn’t reduce thromboembolic events or […]